Arkolith/Insider Trading/SMMT/Form 4

Xia Yu

DirectorSummit Therapeutics Inc. (SMMT) · full profile →Form 4 · filed Oct 23, 2025
Net Buying
Open-Market Buys
$10.0M
Open-Market Sells
$0
Net Open-Market Flow
$10.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 21, 2025Buy(P)534K$18.74$10.0M32.1M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001963544-25-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML